Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04202276
Other study ID # AAAA-?19-119041090031-7
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2017
Est. completion date December 31, 2021

Study information

Verified date January 2022
Source Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This trial is to study the aspects of nutrition in children and adolescents with GERD compared to the sex and age-matched control group


Description:

The aim of the study is to assess the differences in nutrition of pediatric patients with GERD compared to the control group. The secondary aim is to study possible associations of the data on nutritional habits revealed with the use of food frequency questionnaire (FFQ) and the data of 24-hours oesophageal pH-impedance examination.


Recruitment information / eligibility

Status Completed
Enrollment 219
Est. completion date December 31, 2021
Est. primary completion date June 30, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Years to 17 Years
Eligibility Inclusion Criteria: - Willingness to participate (written informed consent and consent from parents or legal representative according to the local law); - Age 6 to 17 years old inclusive, - Possibility to assess symptoms, data of the medical history and receive answers to the questions about usual diet. Exclusion Criteria: - history of abdominal surgery; - presence of varicose veins of the stomach and/or the oesophagus either in medical history or found during the study; - inability to tolerate at least one of the invasive procedures or lacking data of the other instrumental examinations required by protocol; - general condition of the patient making impossible to perform all the examinations or when performing the procedures is not safe and reasonable based on the opinion of the investigator that it may exacerbate the disease flow or put the patient at risk; - intake of medications which may influence the clinical and instrumental data, including, but not limited to: non-steroid anti-inflammatory agents, glucocorticosteroids (except for skin products, if they were used for 2 weeks or less at the time of inclusion into the study), medications affecting adrenergic, acetylcholine receptors, antidepressants, tranquillizers, sedatives, those with known local irritant effect on the gastrointestinal tract mucosa; the use of proton pump inhibitors and H2 receptors blockers are not allowed during the study, a wash-out period for at least 2 weeks is necessary before the enrolment.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
diet assessment
Food frequency questionnaire to investigate differences in diet of children and adolescents with GERD compared to the age- and sex matched control group.

Locations

Country Name City State
Russian Federation Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology Moscow

Sponsors (1)

Lead Sponsor Collaborator
Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology

Country where clinical trial is conducted

Russian Federation, 

Outcome

Type Measure Description Time frame Safety issue
Primary Energy value of the ration value of mean daily consumption of the energy by food frequency questionnaire, kcal/day An average of 1 year
Primary total fat consumption value of mean daily consumption of fats by food frequency questionnaire, G/day An average of 1 year
Primary total carbohydrate consumption value of mean daily consumption of carbohydrates, by food frequency questionnaire, G/day An average of 1 year
Primary total protein consumption value of mean daily consumption of protein by food frequency questionnaire, G/day An average of 1 year
Primary Dietary fibre consumption value of mean daily consumption of dietary fibre, by food frequency questionnaire, G/day An average of 1 year
Secondary Total number of gastroesophageal refluxes This measure is to be obtained by 24-hours oesophageal pH-impedance study 24-hours
Secondary Number of acid gastroesophageal refluxes This measure is to be obtained by 24-hours oesophageal pH-impedance study 24-hours
Secondary Number of weak-acid gastroesophageal refluxes This measure is to be obtained by 24-hours oesophageal pH-impedance study 24-hours
Secondary Number of high gastroesophageal refluxes This measure is to be obtained by 24-hours oesophageal pH-impedance study 24-hours
Secondary Acid exposure time This measure is to be obtained by 24-hours oesophageal pH-impedance study 24-hours
See also
  Status Clinical Trial Phase
Recruiting NCT06084572 - Prospective Evaluation of pH-impedance Tracings According to the Wingate Consensus, and Influence on GERD Classification According to the Lyon Consensus
Completed NCT03568825 - Response Surface Pathway Design With Two Interventional- and One Response Variable in Estimating Minimum Efficacy Dose N/A
Recruiting NCT04703374 - A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects Phase 1
Completed NCT04120025 - Effectiveness of Diaphragmatic Breathing on Reflux Symptoms in Outpatients N/A
Withdrawn NCT04771247 - Endoscopic Cardiac Band Ligation for the Management of Refractory GERD After Laparoscopic Sleeve Gastrectomy N/A
Completed NCT02575287 - Minimal Injuries From Esophagus Detected by Optical Enhancement Systemâ„¢ Associated to Optical Magnification HD Scopes N/A
Completed NCT01710800 - Twenty-Four Hour Combined Multi-Channel Impedance and pH Ambulatory Monitoring: Impedance Reflux Episodes of Patients On and Off Proton Pump Inhibitor Therapy N/A
Completed NCT00287339 - The Utility of Nexium in Chronic Cough and Reflux Disease Phase 4
Completed NCT00287391 - Sleep Disorders and Gastroesophageal Reflux Disease (GERD) Phase 4
Completed NCT00629564 - An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD) Phase 4
Completed NCT04243668 - ANTI REFLUX MUCOSAL ABLATION THERAPHY (ARMA) N/A
Completed NCT03558477 - PK/PD Clinical Trial of YYD601 in Healthy Adult Male Phase 1
Recruiting NCT05042063 - Acoustic Cough Monitoring for the Management of Patients With Known Respiratory Disease
Completed NCT05069493 - Long-term Follow-up After Hiatal Hernia Repair by Tension-free Mesh Closure or Simple Suturing
Terminated NCT04626232 - Comparison of the Sleeve Gastrectomy Technique With a Nissen Fundoplication Added to the Conventional Sleeve Gastrectomy Technique in Morbidly Obese Patients N/A
Completed NCT03238534 - Efficacy and Safety Evaluation of Neobianacid® in GERD and EPS Phase 4
Recruiting NCT05974722 - Mesh Vs Pledgets for Repair of Paraesophageal Hernia N/A
Recruiting NCT05781347 - Stretta Versus Conservative Treatment in Obese and Non-obese N/A
Completed NCT06141577 - A Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of UI059 and UIC202201 in Healthy Subjects Phase 1
Recruiting NCT05108038 - A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects Phase 1

External Links